Can this cheap pill end stunting?
Pregnancy vitamin and mineral supplements are showing more promise than previous solutions Source link
Pregnancy vitamin and mineral supplements are showing more promise than previous solutions Source link
SAVE $50: As of June 12, the Beats Pill speaker is on sale for $99.95 at Amazon. That’s a 33% discount on the list price. $99.95 at Amazon $149.95 Save $50.00 If you’ve had your eye on the Beats Pill speaker, it’s just dropped back down to $99 on Amazon as of June 12, saving you nearly $50 off the usual $149.95. There are three colors to choose from too, including matte black, champagne gold, and statement red. With this speaker you’ll get an impressive battery life, with up to 24 hours of listening time on a single charge. It’s a robust device, rated IP67 for dust and water resistance, so it’s made for a range of outdoor situations. For portability, it even comes with a removable lanyard and soft-grip silicone backing. Beats audio is always one you can rely on, and it’s no different with the Beats Pill. It features a larger racetrack woofer that displaces 90% more air for deeper, fuller bass. It also benefits from high-resolution lossless audio, supported when connected …
Once used legally by long haul truck drivers in Thailand, the drug is now wreaking havoc with lives in Bangladesh Source link
Once used legally by long haul truck drivers in Thailand, yaba is now wreaking havoc with lives in Bangladesh Source link
For many people with type 2 diabetes, the problem is not just finding a drug that works. It is finding one they can realistically live with. A once-daily pill called elecoglipron is now drawing attention because it appears to lower blood sugar and body weight without the food and water restrictions tied to some existing oral options. In a phase 2b clinical trial called SOLSTICE, adults with type 2 diabetes who took oral elecoglipron saw bigger drops in HbA1c, a measure of average blood sugar over the past two to three months, than those who received placebo. The treatment also led to weight loss over 26 weeks, results that add momentum to the search for easier-to-use GLP-1 medicines. The findings were presented at the American Diabetes Association’s 2026 Scientific Sessions and published in The Lancet. Vanita Aroda, a Mass General Brigham physician investigator and director of diabetes clinical research in the Division of Endocrinology, Diabetes & Hypertension, said the results point to a broader future for oral GLP-1 therapies. “Our study’s findings underscore the expanding …
Apple today shared a new Beats Pill ad that pays tribute to the reality TV show Love Island USA, which returned for an eighth season this week. The ad does not mention Love Island USA, but the “Pill People” are said to have “entered the villa,” which is a clear reference to the show. “If you’re binging a full summer of island drama, you’ll need battery life that can keep up,” says Apple. “Good thing the Beats Pill gets up to 24 hours of listening time, more than enough for every recoupling, challenge, and twist the summer has to offer.” Apple released the current Beats Pill in 2024. Priced at $149.99 in the U.S, the speaker comes in Matte Black, Statement Red, and Champagne Gold. Popular Stories Apple Says Mac is ‘Best Choice for College’ in New Ad Aimed at Students Apple today shared a new ad that promotes MacBooks as the “best choice for college.” In the 90-second video, students are frustrated by but eventually overcome creative block while working on assignments like screenplays and …
How many therapies can you think of, off the top of your head? Psychoanalysis probably, but you might also have heard of existential, humanistic, integrative, creative, and body therapies. And then there’s the therapies you might not have heard of like family constellations, internal family systems, transactional analysis, and gestalt therapy. But if you’ve tried to get therapy recently, particularly through a public healthcare system like the National Health Service in the UK or via Medicare in Australia, there’s a good chance you would only have been offered Cognitive Behavioural Therapy. That’s also what you’re most likely to have been recommended if you tried to access therapy through private health insurance or an Employee Assistance Program. I believe Cognitive Behavioural Therapy’s prevalence is not due to it being uncontroversially better than other therapies. Instead, it’s a complicated story about how we evaluate whether something works, what it even means to say it ‘works’, how medical research is funded and how decisions about which interventions to fund are made. It’s a story about Randomised Controlled Trials …
This undated microscope image from USC via the NIH shows pancreatic cancer cells, nuclei in blue, growing as a sphere encased in membranes, red. Min Yu/AP/USC via NIH hide caption toggle caption Min Yu/AP/USC via NIH WASHINGTON — A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types of cancer. “While not curing the cancer, it is a very large step forward,” said Dr. Zev Wainberg, of the University of California, Los Angeles, who helped lead the study. The drug is called daraxonrasib and it blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases — a target that had eluded treatment for decades. The daily pills nearly doubled survival time, with fewer severe side effects, in a study that randomly assigned the experimental drug or more chemotherapy to 500 patients whose metastatic, or spreading, cancer had quit responding to prior treatment. The findings were published in the New England Journal of Medicine …
A daily pill can double survival time in patients with the world’s deadliest cancer, according to the results of a clinical trial that experts are saying is a “gamechanger” and one of the biggest breakthroughs in decades. Currently, there are few treatments for pancreatic cancer, and most do little or nothing to help. For decades, scientists have worked relentlessly trying to find clever solutions for a form of cancer that is often found late. More than half of patients are only diagnosed after it has spread. Now experts at the world’s largest cancer conference are hailing the arrival of a smart drug called daraxonrasib, which they say could pave the way for a treatment revolution. In the trial of 500 patients, all of whom had pancreatic cancer that had spread, the pill doubled survival time, with fewer side-effects compared with chemotherapy. The findings were presented at the American Society of Clinical Oncology’s (Asco) annual meeting in Chicago. Patients who took the drug lived substantially longer, for an average of 13.2 months, compared with 6.6 to …
On Thursday afternoon, the Supreme Court blocked a ruling that had temporarily banned the mailing of mifepristone, a drug used for abortion. In a 7-2 decision, the court ruled against the 5th Circuit, stating that mifepristone can remain accessible via telehealth and mail for now. However, the litigation will continue, pending a final decision by the court. Since the Supreme Court’s 2022 decision on Dobbs v. Jackson Women’s Health Organization overturned Roe v. Wade, medication abortion has become a legal battleground. Two years ago, the court rejected a similar attempt to restrict access to mifepristone in a case brought by Alliance for Hippocratic Medicine. This group claimed that the FDA failed to protect women when it approved the drug. In his dissent, Justice Clarence Thomas argued that pharmaceutical companies “cannot, in any legally relevant sense, be irreparably harmed by a court order that makes it more difficult for them to commit crimes.” Justice Samuel Alito, who also dissented, said that “[w]hat is at stake is the perpetration of a scheme to undermine our decision in …